Oncology Brothers: Practice-Changing Cancer Discussions
By Oncology Brothers
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Oncology Brothers
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 8
Reviews: 0
Episodes: 289
Description
The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients.
Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format.
Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice.
Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities.
If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at info@oncbrothers.com
Privacy Policy: https://oncbrothers.com/privacy-policy
Terms & Conditions: https://oncbrothers.com/terms-and-conditions
| Episode | Date |
|---|---|
|
Rapid Fire Rounds - Thrombocytopenia Workup & Management with Dr. Ronak Mistry
|
Oct 12, 2026 |
|
Challenging Cases in Small Cell Lung Cancer (SCLC) - Drs. Estela Rodriguez & Misty Shields
|
Oct 08, 2026 |
|
WCLC 2026 Highlights: MAVERICK, ADAURA, HARMONi, PAPILLON, DESTINY-Lung04 with Dr. Christine Lovly
|
Oct 05, 2026 |
|
Managing Toxicities of HER2+ Therapies in Upper GI Cancer - Trastuzumab, T-DXd, Zanidatamab
|
Sep 30, 2026 |
|
Upper GI Treatment Algorithm (Esophageal, Gastric, GEJ) - Dr. Sam Klempner
|
Sep 28, 2026 |
|
Follicular & Mantle Cell Lymphoma Treatment Algorithm: Dr. Jonathan Friedberg
|
Sep 24, 2026 |
|
Diffuse Large B-cell Lymphoma (DLBCL) Treatment Algorithm: Dr. Mazyar Shadman
|
Sep 22, 2026 |
|
Revolution Medicines CEO Dr. Mark Goldsmith: Daraxonrasib dream to reality
|
Sep 21, 2026 |
|
Camizestrant + CDK 46i FDA Approval in Hormone Receptor Positive Breast Cancer SERENA-6
|
Sep 16, 2026 |
|
SURPASS-ET: FDA Approval of Ropeginterferon alfa-2b in Essential Thrombocythemia (ET)
|
Sep 14, 2026 |
|
Myelofibrosis Treatment Algorithm Discussion: Dr. Nico Gagelmann
|
Sep 07, 2026 |
|
Managing Toxicities of Therapies in Polycythemia Vera (PV) / Essential Thrombocythemia (ET)
|
Sep 04, 2026 |
|
VERIFY: FDA Approval of Rusfertide in Polycythemia Vera (PV) - Dr. Andrew Kuykendall
|
Sep 02, 2026 |
|
Polycythemia vera (PV) and Essential thrombocythemia (ET) Treatment Algorithm: Dr. Aaron Gerds
|
Aug 31, 2026 |
|
Multiple Myeloma Management - Partners in Practice with Dr. Ajai Chari Team from UCSF
|
Aug 27, 2026 |
|
HERIZON-GEA-01: FDA Approval of Zanidatamab + Tislelizumab for HER2+ Esophageai/GEJ/Gastric Adeno
|
Aug 25, 2026 |
|
Rapid Fire Rounds - Multiple Myeloma Management with Dr. Joseph Mikhael
|
Aug 24, 2026 |
|
EXCALIBER-RRMM - Iberdomide/Dara/Dex FDA Approval for R/R Multiple Myeloma: Dr. Sagar Lonial
|
Aug 20, 2026 |
|
Managing Toxicities of Androgen Receptor Pathway Inhibitor (ARPI) in Prostate Cancer
|
Aug 17, 2026 |
|
Challenging Cases in Myelodysplastic Syndrome (MDS) - Dr. Amer Zeidan
|
Aug 13, 2026 |
|
Treatment Algorithm of Myelodysplastic Syndrome (MDS) in 2026 - Dr. Thomas LeBlanc
|
Aug 10, 2026 |
|
Pancreatic Cancer Management - Partners in Practice with Dr. Tim Brown & Ms. Heather Kline
|
Aug 06, 2026 |
|
Treatment Algorithm of Late Relapsed/Refractory Multiple Myeloma (RRMM)
|
Aug 03, 2026 |
|
Treatment Algorithm of Early Relapsed/Refractory Multiple Myeloma (RRMM)
|
Jul 30, 2026 |
|
ENDURANCE Trial - Time-limited Lenalidomide Maintenance for Standard Risk Myeloma
|
Jul 28, 2026 |
|
Managing Toxicities of CAR-T in Multiple Myeloma (MM) – Drs. Caitlin Costello & Joshua Richter
|
Jul 23, 2026 |
|
Challenging Cases in Relapsed/Refractory Multiple Myeloma - Drs. Marco Davila & Krina Patel
|
Jul 20, 2026 |
|
Treatment Algorithm of Smoldering Myeloma & Newly Diagnosed Multiple Myeloma (NDMM)
|
Jul 16, 2026 |
|
EHA2026 Leukemia Highlights: OPTI-AML, KOMET-007, SENTRY
|
Jul 13, 2026 |
|
Challenging Cases in Diffuse Large B-cell Lymphoma (DLBCL) – Drs. Gilles Salles & Matt Lunning
|
Jul 09, 2026 |
|
EHA2026 Lymphoma Highlights: frontMIND, POLAR-BEAR, HD-MTX for CNS Lymphoma, EPCORE FL-1
|
Jul 06, 2026 |
|
Sacituzumab +/- Pembrolizumab FDA Approval in Triple Negative Breast Cancer: ASCENT-03 / ASCENT-04
|
Jul 04, 2026 |
|
ASCO 2026 Breast Highlights: OPTIMA, lidERA, VIKTORIA-1, KEYNOTE-522, ASCENT-03/04, TROPION-Breast02
|
Jul 02, 2026 |
|
EHA2026 Multiple Myeloma Highlights: CEPHEUS, MajesTEC-3, MajesTEC-9, MonumenTAL-3, SUCCESSOR-2
|
Jun 29, 2026 |
|
Evolving Treatment Landscape of Multiple Myeloma: Bispecifics, CAR T, and CELMoDs
|
Jun 26, 2026 |
|
Challenging Cases - Treatment of Renal Cell Carcinoma (RCC): Dr. Pedro Barata
|
Jun 25, 2026 |
|
ASCO 2026 GU Highlights & FDA Approvals with Drs. Brian Rini & Tom Powles (The Uromigos)
|
Jun 22, 2026 |
|
To hold or NOT to hold Systemic Therapy with Radiation: Dr. Nina Sanford
|
Jun 18, 2026 |
|
ASCO 2026 GI Highlights: EMERALD-3, FIGHT-302, CIRCULATE, MATTERHORN
|
Jun 15, 2026 |
|
RASolute 302 Pancreatic Cancer Study with Daraxonrasib at ASCO 2026 – Dr. Brian Wolpin
|
Jun 11, 2026 |
|
ASCO 2026 Head & Neck AND Sarcoma Highlights – Drs. Samantha Armstrong & Ari Rosenberg
|
Jun 08, 2026 |
|
Challenging Cases - Treatment of Common EGFR Mutations in Metastatic Non-Small Cell Lung Cancer
|
Jun 08, 2026 |
|
Lung Cancer ASCO 2026 Highlights: LIBRETTO-432, CROWN Update, CHRYSALIS-2, HARMONi-6
|
Jun 05, 2026 |
|
RASolute-302 with Daraxonrasib - Game Changer at ASCO 2026 in Pancreatic Cancer
|
Jun 01, 2026 |
|
ESMO Breast 2026 Highlights - VERITAC-2, PREcoopERA, PHERGain, SATEEN/BRE-354, TROPION-Breast02
|
May 26, 2026 |
|
Challenging Cases in Relapsed/Refractory Acute Myeloid Leukemia (AML): Dr. Joshua Zeidner
|
May 25, 2026 |
|
Challenging Cases in Chronic Myeloid Leukemia (CML): Drs. Fadi Haddad & Gaby Hobbs
|
May 22, 2026 |
|
Managing Toxicities of BRAF-MEK Inhibitors in Non-Small Cell Lung Cancer – Dr. Melissa Johnson
|
May 20, 2026 |
|
Treating BRAF V600E Mutated Non-Small Cell Lung Cancer (NSCLC) with Dr. Gregory Riely
|
May 18, 2026 |
|
Managing Toxicities of Bispecific Antibodies in Multiple Myeloma–Drs. Hamza Hashmi & Cesar Rodriguez
|
May 15, 2026 |
|
Managing Toxicities of EGFR Inhibitors in Lung Cancer – Drs. Azam Farooqui & Joshua Sabari
|
May 13, 2026 |
|
How to Treat Metastatic NSCLC with Targetable Mutations – Treatment Algorithm with Dr. Eric Singhi
|
May 11, 2026 |
|
How to Treat Metastatic NSCLC W/O Targeted Mutations – Treatment Algorithm with Dr. Christine Garcia
|
May 07, 2026 |
|
How to Treat Localized Non-Small Cell Lung cancer – Treatment Algorithm with Dr. Sanjay Popat
|
May 04, 2026 |
|
How to Treat Small Cell Lung Cancer (SCLC) – Treatment Algorithm with Dr. Jacob Sands
|
Apr 30, 2026 |
|
Managing Toxicities of Colorectal Cancer Drugs / Systemic Therapy – Dr. Rona Yaeger
|
Apr 27, 2026 |
|
BREAKWATER Study for BRAF V600E Mutated Colorectal Cancer – Encorafenib + Cetuximab + Chemotherapy
|
Apr 23, 2026 |
|
How to Treat Colorectal Cancer – Treatment Algorithm with Dr. Smitha Krishnamurthi
|
Apr 20, 2026 |
|
How to Treat Pancreatic Cancer – Treatment Algorithm with Dr. Shubham Pant
|
Apr 16, 2026 |
|
How to Treat Biliary Tract Cancer – Treatment Algorithm with Dr. Suneel Kamath
|
Apr 09, 2026 |
|
How to Treat Cancer of Unknown Primary (CUP) Origin – Drs. Harry Fuentes & Thor Halfdanarson
|
Apr 06, 2026 |
|
How to Treat Bladder Cancer – Drs. Stephanie Berg (Medical Oncologist) & Joshua Meeks (Urologist)
|
Apr 02, 2026 |
|
Open Evidence as an Artificial Intelligence (AI) Tool in the World of Medicine
|
Mar 30, 2026 |
|
How to Treat Renal Cell Carcinoma (RCC) in 2026 – Dr. Katy Beckermann
|
Mar 26, 2026 |
|
Evolving Treatment Landscape of HER2+ Upper GI Cancer
|
Mar 23, 2026 |
|
How to Treat Prostate Cancer Localized to Advanced Settings - Dr. Scott Tagawa
|
Mar 19, 2026 |
|
Pre-analytical phase challenges and biomarker testing in HER2+ metastatic breast cancer
|
Mar 16, 2026 |
|
GU ASCO 2026 Highlights – CREST, POTOMAC, EV-304/KEYNOTE-B15, LITESPARK-011/022, CAPITELLO-281
|
Mar 12, 2026 |
|
Clinical Insights: Evolving Landscape of Bladder Cancer After GU ASCO 2026
|
Mar 09, 2026 |
|
Teclistamab-Daratumumab FDA Approval of MajesTEC-3 for R/R Multiple Myeloma (MM): Dr. Luciano Costa
|
Mar 07, 2026 |
|
Triple Negative Breast Cancer (TNBC) Treatment Algorithm: Dr. Tiffany Traina
|
Mar 05, 2026 |
|
Combination Approaches in PD-L1–Positive Metastatic Triple Negative Breast Cancer
|
Mar 02, 2026 |
|
HER2+ Breast Cancer Treatment Algorithm: Dr. Virginia Kaklamani
|
Feb 25, 2026 |
|
Metastatic Hormone Receptor Positive (HR+) Breast Cancer Treatment Algorithm: Dr. Kevin Kalinsky
|
Feb 19, 2026 |
|
Early Stage Hormone Receptor Positive (HR+) Breast Cancer Treatment Algorithm: Dr. Erica Mayer
|
Feb 12, 2026 |
|
Current & Future Role of Anktiva (N-803): Dr. Patrick Soon-Shiong
|
Feb 09, 2026 |
|
Trastuzumab deruxtecan (T-DXd) + Pertuzumab FDA Approval in Adv HER2 Breast Cancer: DESTINY-Breast09
|
Feb 05, 2026 |
|
Navigating Acute Myeloid Leukemia Treatment: Therapy-Related & De Novo AML with Dr. Naval Daver
|
Feb 03, 2026 |
|
Head & Neck Cancers Treatment Landscape & Algorithm – Dr. Fangdi Sun
|
Jan 26, 2026 |
|
FDA Approval of Daratumumab in High Risk Smoldering Myeloma: AQUILA by Dr. Vincent Rajkumar
|
Jan 22, 2026 |
|
ASH 2025 Multiple Myeloma Highlights – AQUILA, COBRA, TecLILLE, MajesTEC-3: Dr. Ben Derman
|
Jan 19, 2026 |
|
GI ASCO 2026 Highlights MATTERHORN, HERIZON-GEA-01, BREAKWATER, COMMIT – Dr. Rachna Shroff
|
Jan 15, 2026 |
|
ASH 2025 Lymphoma Highlights - EPCORE FL-1, CLL-17, BRUIN CLL-313, SWOG-1826: Dr. Julie Vose
|
Jan 11, 2026 |
|
ASH 2025 Leukemia Highlights PARADIGM, KOMET-007, ASC4FIRST, ASC2ESCALATE - Dr. Jorge Cortes
|
Jan 07, 2026 |
|
HER2+ SABCS 2025 Highlights DESTINY Breast-05/Breast-11, HER2CLIMB-05, PATINA: Dr. Harold Burstein
|
Jan 05, 2026 |
|
Triple Negative Breast Cancer SABCS 2025 Highlights: Dr. Rebecca Shatsky
|
Jan 03, 2026 |
|
Enfortumab vedotin + Pembro FDA Approval in Muscle Invasive Bladder Cancer (MIBC): Dr. Thomas Powles
|
Dec 31, 2025 |
|
Metastatic HR+ Breast Cancer SABCS 2025 Highlights: Dr. Hope Rugo
|
Dec 26, 2025 |
|
Early HR+ Disease SABCS 2025 Practice Changing/Informing Highlights: ALTTO, lidERA, NATALEE
|
Dec 22, 2025 |
|
Advancements and Challenges in Metastatic Colorectal Cancer Treatment
|
Dec 21, 2025 |
|
Clinical Implications of Testing HER2 and Targeted Therapies Approved - Dr. Komal Jhaveri
|
Dec 19, 2025 |
|
Toxicity Management of HER2+ Treatment Options in Upper GI Cancers – Drs. Geoffrey Ku & Shruti Patel
|
Dec 18, 2025 |
|
Current Treatment Landscape of Advanced Gastric/Esophageal/GEJ Adenocarcinoma – Dr. Rutika Mehta
|
Dec 15, 2025 |
|
Managing Toxicities of Antibody Drug Conjugates (ADCs) in Lung Cancer – Dr. Jacob Sands
|
Dec 13, 2025 |
|
Managing Toxicities of PI3K & AKT Inhibitors in Breast Cancer – Drs. Emily Gallagher & Neil Iyengar
|
Dec 11, 2025 |
|
Challenging Cases of Iron Abnormalities, Anemia or Iron Overload - Dr. Marina Beltrami
|
Dec 04, 2025 |
|
FDA Approval of Epcoritamab-Rituximab-Lenalidomide for R/R Follicular Lymphoma – Dr. Gilles Salles
|
Dec 04, 2025 |
|
Challenging Cases in Second Line & Beyond Renal Cell Carcinoma (RCC) - Dr. David Braun
|
Nov 30, 2025 |
|
FDA Approval of Durvalumab with FLOT in Resectable Gastric & GEJ: MATTERHORN by Dr. Yelena Janjigian
|
Nov 26, 2025 |
|
Challenging Cases in Breast Cancer with CDK 4/6 Inhibitors – Drs. Sara Tolaney & Adam Brufsky
|
Nov 24, 2025 |
|
Challenging Cases in Non-Muscle Invasive Bladder Cancer (NMIBC) – Drs. Shilpa Gupta & Joshua Meeks
|
Nov 20, 2025 |
|
FDA Approval of Ziftomenib (KOMET-001) in NPM1 mut Acute Myeloid Leukemia (AML) – Dr. Eunice Wang
|
Nov 17, 2025 |
|
Managing Toxicities of ROS1 Inhibitors in Non-Small Cell Lung Cancer (NSCLC) – Dr. Estela Rodriguez
|
Nov 13, 2025 |
|
Managing Toxicities of Tyrosine Kinase Inhibitors (TKI) in CML - Drs. Onyee Chan & Fadi Haddad
|
Nov 10, 2025 |
|
Lung Cancer ESMO 2025 Highlights: MDT-BRIDGE, FLAURA2, SOHO-01, Beamion LUNG-1
|
Nov 06, 2025 |
|
GI Cancer ESMO 2025 Highlights: DYNAMIC-III, PEGASUS, STELLAR-303, MATTERHORN, FORTITUDE-101
|
Nov 03, 2025 |
|
Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE, VIKTORIA1, evERA, DESTINY, ASCENT, TROPION
|
Oct 30, 2025 |
|
Current Treatment Landscape of Ovarian Cancer with Dr. Sharyn Lewin
|
Oct 27, 2025 |
|
GU Cancer ESMO 2025 Highlights: PSMAddition, Capitello-281, Potomac, Keynote-905, IMVigor011
|
Oct 23, 2025 |
|
Challenging Cases with Metastatic EGFR Mutated Non-Small Cell Lung Cancer with Dr. Eric Singhi
|
Oct 20, 2025 |
|
Managing Toxicities of CDK4/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff
|
Oct 16, 2025 |
|
Treating and Managing Chronic Myeloid Leukemia (CML) in 2025: Dr. Jorge Cortes
|
Oct 13, 2025 |
|
How to Manage Thrombocytopenia (ITP, HIT, DIC, TTP) - Dr. Ronak Mistry
|
Oct 09, 2025 |
|
IMforte - Maintenance Lurbinectedin + Atezo FDA Approval for Extensive Small Cell Lung Cancer (SCLC)
|
Oct 06, 2025 |
|
Exploring the role of targeted radiopharmaceutical treatment in NETs
|
Oct 02, 2025 |
|
Challenging Cases of Venous Thromboembolism (VTE) - Drs. Jennifer Vaughn & Nicolas Gallastegui
|
Sep 29, 2025 |
|
How to Treat Cutaneous Melanoma in 2025 - Dr. Omid Hamid
|
Sep 25, 2025 |
|
Treatment Algorithm of Neuroendocrine Tumors (NET) in 2025 - Dr. Thor Halfdanarson
|
Sep 22, 2025 |
|
WCLC 2025 Highlights: FLAURA2, HARMONi, ALCHEMIST with Dr. Balazs Halmos
|
Sep 18, 2025 |
|
Treating and Managing Chronic Lymphocytic Leukemia (CLL) in 2025: Dr. Mazyar Shadman
|
Sep 11, 2025 |
|
Managing Side Effects of New Treatments for Small Cell Lung Cancer
|
Aug 29, 2025 |
|
FDA Approval of Zongertinib for HER2 Mutated Non-Small Cell Lung Cancer (NSCLC) - Dr. Joshua Sabari
|
Aug 25, 2025 |
|
Latest Clinical Data for First-line Maintenance and R/R Small-Cell Lung Cancer (SCLC)
|
Aug 21, 2025 |
|
FDA Approval of Datopotamab deruxtecan (Dato-DXd) in EGFR Mutated Lung Cancer - Dr. Jacob Sands
|
Aug 18, 2025 |
|
Diagnosis and Treatment of Myelofibrosis with Dr. Raajit Rampal: Testing, Treatment, Supportive care
|
Aug 11, 2025 |
|
Managing Toxicities of TKIs and HIF-2 inhibitor in Renal Cell Carcinoma (RCC)
|
Aug 07, 2025 |
|
Myeloproliferative Neoplasms (MPN) Treatment: Polycythema Vera (PV) & Essential Thrombocythemia (ET)
|
Aug 04, 2025 |
|
Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer
|
Jul 31, 2025 |
|
Challenging Cases with Relapsed/Refractory FLT3+ Acute Myeloid Leukemia (AML)
|
Jul 28, 2025 |
|
Treating Acute Myeloid Leukemia in 2025 - Induction, Consolidation, Transplant, Target Therapies
|
Jul 24, 2025 |
|
Challenging Cases with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
|
Jul 21, 2025 |
|
How to Treat Diffuse Large B-Cell Lymphoma (DLBCL) in 2025
|
Jul 17, 2025 |
|
How to Treat Early Stage Non-Small Cell Lung Cancer in 2025
|
Jul 10, 2025 |
|
ASCO 2025 - GU Cancer Highlights: KEYNOTE-564, AMPLITUDE, ARANOTE, NIAGARA
|
Jul 04, 2025 |
|
FDA Approval of Telisotuzumab (Teliso-V) in c-MET Overexpression - LUMINOSITY trial
|
Jun 27, 2025 |
|
ASCO 2025 - Breast Cancer Highlights: INAVO120, SERENA-6, VERITAC-2, DESTINY-Breast09, ASCENT-04
|
Jun 20, 2025 |
|
ASCO 2025 - GI Cancer Highlights: DYNAMIC III, ATOMIC, BREAKWATER, MATTERHORN, DESTINY Gastric04
|
Jun 14, 2025 |
|
ASCO 2025 Lung Cancer Highlights: CheckMate 816, ToD, NeoADAURA, IMforte, DeLLphi 304
|
Jun 07, 2025 |
|
Nivolumab plus Ipilimumab in Microsatellite-Instability–High (MSI-H) Metastatic Colorectal Cancer
|
May 26, 2025 |
|
Managing Toxicities of EGFR Inhibitors: Afatinib, Amivantamab-Lazertinib, Osimertinib
|
May 21, 2025 |
|
How to treat Small Cell Lung Cancer in 2025
|
May 19, 2025 |
|
Treatment of Metastatic Non-Small Cell Lung Cancer With Targeted Mutations
|
May 15, 2025 |
|
How to Treat Metastatic Non-Small Cell Lung Cancer (NSCLC) Without Targeted Mutations
|
May 12, 2025 |
|
Managing Side Effects of HER2 Targeted Therapy - Zanidatamab & Trastuzumab deruxtecan (T-DXd)
|
May 08, 2025 |
|
Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer
|
May 05, 2025 |
|
Treatment Options for HER2 Positive Biliary Tract Cancers
|
May 01, 2025 |
|
The HER2 Diagnostic and Treatment Landscape in NSCLC
|
Apr 29, 2025 |
|
Overview of Biliary Tract Cancer & Importance of Targeted Therapies
|
Apr 24, 2025 |
|
What does it mean to be HER2 Positive in Lung Cancer
|
Apr 21, 2025 |
|
European Lung Cancer Conference (ELCC) 2025 Highlights: KEYNOTE-799, LAURA, MARIPOSA, KRYSTAL-7
|
Apr 14, 2025 |
|
FDA Approval of Cabozantinib - CABINET in pNET and epNET
|
Apr 10, 2025 |
|
How to Manage & Treat Pancreatic Cancer
|
Apr 07, 2025 |
|
How to Treat Upper Gastrointestinal Cancers in 2025 - Treatment Algorithm
|
Mar 31, 2025 |
|
ToxCheck: Managing Side Effects of Pancreatic Cancer Treatment
|
Mar 27, 2025 |
|
Prostate Cancer Management from Early Stage to Advanced Metastatic Disease - Dr. Alan Bryce
|
Mar 24, 2025 |
|
How to Treat Renal Cell Carcinoma (RCC) using a Treatment Algorithm with Dr. Katy Beckermann
|
Mar 17, 2025 |
|
How to Treat Bladder Cancer in 2025 with Dr. Joaquim Bellmunt
|
Mar 10, 2025 |
|
FDA Approval of Tislelizumab - RATIONALE 305 and 306 in Upper GI Cancers
|
Mar 06, 2025 |
|
GU ASCO 2025 Highlights - TALAPRO-2, NIAGARA, CheckMate-9ER, TiNivo-2
|
Mar 03, 2025 |
|
How to Treat Hormone Receptor Positive Cancer - Latest Advancements and Current Standard of Care in 2025
|
Feb 24, 2025 |
|
FDA Approval of Zolbetuximab SPOTLIGHT / GLOW study - Upper GI Cancer with Claudin 18.2 Mutation
|
Feb 21, 2025 |
|
How to Treat HER2+ Breast Cancer - Discussion with Dr. Sarah Sammons
|
Feb 17, 2025 |
|
How to Treat Triple Negative Breast Cancer - Discussion with Dr. Virginia Kaklamani
|
Feb 10, 2025 |
|
GI ASCO 2025 Highlights - BREAKWATER, CheckMate-8HW, ALASCCA, STARTER-NET
|
Feb 03, 2025 |
|
FDA Approval of Subcutaneous Nivolumab CheckMate-67T - Subcutaneous Nivo vs. Intravenous (IV) Nivo
|
Jan 31, 2025 |
|
Intermediate HCC – the evolving role of Immunotherapy with Multimodality approaches
|
Jan 27, 2025 |
|
Managing Side Effects of Anti-VEGF Bevacizumab & Anti-EGFR Cetuximab and Panitumumab
|
Jan 22, 2025 |
|
ASH Lymphoma 2024 Highlights - POLARIX Update, inMIND, TRIANGLE, ENRICH with Dr. Pallawi Torka
|
Jan 21, 2025 |
|
SABCS 2024 Highlights - DESTINY-Breast06, DESTINY-Breast12, PATINA with Dr. Sara Tolaney
|
Jan 17, 2025 |
|
SABCS 2024 Highlights - EUROPA, TAILORx, PADMA, EMBER-3 with Dr. Jame Abraham
|
Jan 15, 2025 |
|
Intermediate Hepatocellular Carcinoma (HCC) – Treatment Options & Strategies
|
Jan 13, 2025 |
|
SABCS 2024 Highlights - INSEMA, KEYNOTE-522, OlympiA
|
Jan 09, 2025 |
|
Multiple Myeloma ASH 2024 Highlights with Dr. Robert Orlowski
|
Jan 07, 2025 |
|
FDA Approval of Zanidatamab - HERIZON-BTC-01 Discussion with Dr. Shubham Pant
|
Jan 02, 2025 |
|
ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL, Role of CAR-T Cell Therapy
|
Dec 26, 2024 |
|
CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects of CAR-T Therapy
|
Dec 21, 2024 |
|
Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens
|
Dec 19, 2024 |
|
2nd line treatment in advanced HCC and when to switch
|
Dec 13, 2024 |
|
From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer
|
Dec 02, 2024 |
|
The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)
|
Nov 28, 2024 |
|
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
|
Nov 25, 2024 |
|
How to Approach and Treat Pancreatic Cancer
|
Nov 21, 2024 |
|
Understanding the Impact of Nutrition & Exercise on Cancer Outcomes
|
Nov 18, 2024 |
|
How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)
|
Nov 14, 2024 |
|
Palliative Care Management in Cancer
|
Nov 08, 2024 |
|
How to Approach to Ovarian Cancer from Community Oncology Perspective
|
Oct 31, 2024 |
|
How to Approach to Endometrial Cancer from Community Oncology Perspective
|
Oct 24, 2024 |
|
DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)
|
Oct 22, 2024 |
|
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
|
Oct 20, 2024 |
|
Lung Cancer ESMO 2024 Highlights: Key Studies Discussed LAURA, MARIPOSA, MARIPOSA-2, ADRIATIC
|
Oct 17, 2024 |
|
AGAVE-201 Study - FDA Approval of Axatilimab for Chronic Graft-versus-Host Disease (cGVHD)
|
Oct 15, 2024 |
|
How to Approach to Acute Myeloid Leukemia (AML) from Community Oncology Perspective
|
Oct 13, 2024 |
|
GI Cancer ESMO 2024 Highlights: Key Studies Discussed LEAP-012, KEYNOTE-811, POD1UM-303, NICHE-2
|
Oct 10, 2024 |
|
GU Cancer ESMO 2024 Highlights: Key Studies Discussed NIAGARA, TiNiVO-2, PEACE-3, CONTACT-02
|
Oct 03, 2024 |
|
Breast Cancer ESMO 2024 Highlights: Key Studies Discussed NATALEE, KEYNOTE 522, DESTINY-Breast12
|
Sep 26, 2024 |
|
WCLC 2024 Highlights - Exploring Latest Advances in Lung Cancer Treatment
|
Sep 19, 2024 |
|
How to Treat Chronic Myeloid Leukemia (CML) - Dr. Jorge Cortes
|
Aug 29, 2024 |
|
How to Treat Follicular & Mantle Cell Lymphomas - Discussion with Dr. Pallawi Torka
|
Aug 22, 2024 |
|
How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo
|
Aug 15, 2024 |
|
How to treat Cutaneous Melanoma (Skin Cancer) - Dr. Allison Betof Warner
|
Aug 08, 2024 |
|
Role of Cardiology in Cancer Treatment: Cardio-Oncology
|
Aug 05, 2024 |
|
How to Treat Early Stage Non-Small Cell Lung Cancer
|
Aug 01, 2024 |
|
How to Treat Metastatic Non-Small Cell Lung Cancer w/o Targeted Mut in Front-line - Dr. Preeshagul
|
Jul 25, 2024 |
|
How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos
|
Jul 18, 2024 |
|
How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi
|
Jul 08, 2024 |
|
GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis
|
Jun 24, 2024 |
|
GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri
|
Jun 20, 2024 |
|
Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton
|
Jun 17, 2024 |
|
Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari
|
Jun 12, 2024 |
|
Multidisciplinary Treatment Approach for Rectal Cancer - Discussion with Drs. Deb Schrag & Krishan Jethwa
|
May 27, 2024 |
|
Zanubrutinib - FDA Approval, Efficacy & Safety Profile in CLL - Discussion with Dr. Shadman
|
May 23, 2024 |
|
How to treat Myelofibrosis - Discussion with Dr. Naveen Pemmaraju
|
May 20, 2024 |
|
Understanding Disparities in Colorectal Cancer Care
|
May 16, 2024 |
|
Relapsed/Refractory Multiple Myeloma Treatment Algorithm with Dr. Samer Al’Hadidi
|
May 13, 2024 |
|
Liver Directed Therapies - Interventional Radiology & Radiation Oncologist Perspective
|
May 09, 2024 |
|
Discussing Treatment Algorithm for Newly Diagnosed Multiple Myeloma with Dr. Caitlin Costello
|
May 06, 2024 |
|
Discussion on Evolving CLL Treatment Strategies with Dr. Nitin Jain
|
Apr 29, 2024 |
|
FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
|
Apr 25, 2024 |
|
Standard of Care Treatment for Upper GI Cancer: A Discussion with Dr. Sam Clempner
|
Apr 22, 2024 |
|
Standard of Care Treatment for Colon Cancer: A Discussion with Dr. Aparna Parikh
|
Apr 10, 2024 |
|
Unpacking the Treatment Algorithm of Hepatocellular Carcinoma with Dr. Tanios S. Bekaii-saab
|
Apr 01, 2024 |
|
Breakthrough in Bladder Cancer: FDA approval - Enfortumab Vedotin + Pelbrolizumab with Dr. Tom Powles
|
Mar 27, 2024 |
|
Bladder Cancer Treatment Algorithm Discussion with Drs. Karine Tawagi and Sia Daneshmand
|
Mar 22, 2024 |
|
Exploring the Latest in Renal Cell Cancer Therapies with Dr. Monty Pal using an Algorithm
|
Mar 11, 2024 |
|
How to treat Prostate Cancer in 2024 with Dr. Rana McKay
|
Feb 26, 2024 |
|
Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 Study
|
Feb 22, 2024 |
|
How to Treat HR+ Breast Cancer with Dr. Virginia Kaklamani | Onc Brothers
|
Feb 15, 2024 |
|
GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564
|
Feb 08, 2024 |
|
How to treat HER2+ Breast Cancer in 2024 with Dr. Harold Burstein
|
Feb 05, 2024 |
|
GI ASCO 2024 Highlights with Dr. Pamela Kunz – CheckMate 8HW, EMERALD-1, NETTER-2
|
Feb 01, 2024 |
|
How to Treat Triple Negative Breast Cancer | Dr. Ruth O'Regan Chair & Dr. Anna Weiss
|
Jan 24, 2024 |
|
ASH 2023 Leukemia/MDS/Myelofibrosis Highlights – TRANSFORM-1, MANIFEST-2, SAVE, AUGMENT-101 with Dr. Uma Borate
|
Jan 17, 2024 |
|
SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02
|
Jan 11, 2024 |
|
SABCS 2023 Breast Cancer Highlights – NATALEE, MONARCH-3, INAVO120, TROPION-Breast01
|
Jan 08, 2024 |
|
ASH 2023 CLL/Lymphoma Highlights – ALPINE, SEQUOIA, SWOG-S1826, POLARIX Update with Dr. Mazyar Shadman
|
Dec 21, 2023 |
|
ASH 2023 Multiple Myeloma Highlights – PERSEUS, IsKia, Bortezomib dosing, KarMMA-3 Update with Dr. Jens Hillengass
|
Dec 19, 2023 |
|
SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update
|
Dec 15, 2023 |
|
How to Treat Myelodysplastic Syndrome (MDS) with Dr. Amer Zeidan
|
Nov 24, 2023 |
|
ESMO 2023 GI Cancer Highlights – Codebreak300, CABINET, GASTFOX
|
Nov 16, 2023 |
|
ESMO 2023 Lung Cancer - Chapter 2 Highlights – PAPILLON, MARIPOSA, MARIPOSA-2, LIBRETTO-431
|
Nov 13, 2023 |
|
ESMO 2023 Breast Cancer Highlights – Keynote 756, TROPION-Breast01, Keynote 52 | Onc Brothers
|
Nov 09, 2023 |
|
ESMO 2023 GU Cancer Highlights – SunRISE-1, EV-302, PSMAfore
|
Nov 06, 2023 |
|
ESMO 2023 Lung Cancer Highlights – Keynote 671 | ALINA | TropionLung01 | Oncology Brothers
|
Nov 02, 2023 |
|
How to Treat Cutaneous Melanoma - Deep Dive with Dr. Sapna Pate
|
Oct 12, 2023 |
|
2023 World Conference on Lung Cancer Highlights | Dr. Stephen Liu | Oncology Brothers #2023
|
Sep 21, 2023 |
|
How to Treat Chronic Lymphocytic Leukemia (CLL) with Dr. Jeff Sharman
|
Sep 14, 2023 |
|
Polatuzumab FDA Approval in DLBCL (POLARIX) & SWOG S1826 Nivo vs. BV in Hodgkin’s Lymphoma
|
Aug 31, 2023 |
|
Story of Hope by a Determined Lung Cancer Survivor - Jill Feldman
|
Aug 10, 2023 |
|
EV-103 Study by Dr. Jonathan Rosenberg led to the FDA Approval of Enfortumab + Pembrolizumab
|
Jul 31, 2023 |
|
How to Treat MGUS and Smoldering Myeloma with Dr. S. Vincent Rajkumar
|
Jul 27, 2023 |
|
How to Treat Multiple Myeloma with Dr. Jens Hillengass
|
Jul 20, 2023 |
|
Critical Updates in Kidney, Prostate, and Bladder Cancer from ASCO 2023 with Dr. Toni Choueiri
|
Jul 06, 2023 |
|
GI Cancer ASCO 2023 Highlights with Dr. Muhammad Shaalan Beg
|
Jun 29, 2023 |
|
Lung Cancer ASCO 2023 Highlights with Dr. Charu Aggarwal
|
Jun 22, 2023 |
|
Breast Cancer ASCO 2023 Highlights with Dr. Stephanie Graff
|
Jun 15, 2023 |
|
EMERALD Ph III Study in discussion w/ Dr. Virginia Kaklamani (now FDA Approved)
|
May 18, 2023 |
|
Colon Cancer Algorithm Discussion with Dr. Cathy Eng
|
May 08, 2023 |
|
American Association for Cancer Research (AACR) 2023 Highlights from Community Oncology
|
Apr 28, 2023 |
|
HR+ Breast Cancer Management with Dr. Margaret Gatti-Mays
|
Apr 20, 2023 |
|
HR+ Invasive Lobular Carcinoma Management with Dr. Jason Mouabbi
|
Apr 10, 2023 |
|
HER2+ Breast Cancer Algorithm Discussion with Dr. Paolo Tarantino
|
Apr 03, 2023 |
|
Metastatic Non-Small Cell Lung Cancer (NSCLC) Algorithm w/ Targetable Mutations - Dr. Jarushka Naidoo
|
Mar 27, 2023 |
|
Metastatic Non-Small Cell Lung Cancer (NSCLC) Algorithm w/o Targetable Mutations - Dr. Eric Singhi
|
Mar 20, 2023 |
|
Localized Non-Small Cell Lung Cancer (NSCLC) Algorithm with Dr. Charu Aggarwal
|
Mar 13, 2023 |
|
Small Cell Lung Cancer (SCLC) Algorithm with Dr. Estelamari Rodriguez
|
Mar 02, 2023 |
|
MOUNTAINEER Study in discussion w/ Dr. Bekaii-Saab (Tucatinib and Trastuzumab FDA Approval for advanced colorectal cancer)
|
Feb 27, 2023 |
|
GU ASCO 2023 Highlights with Dr. Petros Grivas
|
Feb 22, 2023 |
|
Prostate Cancer Algorithm with Dr. Neeraj Agarwal
|
Feb 09, 2023 |
|
EMERALD Ph III Study in discussion w/ Dr. Aditya Bardia (now FDA Approved)
|
Feb 02, 2023 |
|
GI ASCO 2023 Highlights with Dr. Mark Lewis
|
Jan 26, 2023 |
|
The NICHE-2 Study Discussion with Dr. Myriam Chalabi
|
Jan 16, 2023 |
|
Bladder Cell Cancer Algorithm Discussion with Dr. Andrea Apolo
|
Jan 13, 2023 |
|
Kidney / Renal Cell Cancer Algorithm Discussion with Dr. Elizabeth Plimack
|
Jan 05, 2023 |
|
DESTINY-Breast04 Study Discussion with Dr. Shanu Modi
|
Dec 30, 2022 |
|
TNBC SABCS 2022 Highlights with Dr. Maryam Lustberg
|
Dec 21, 2022 |
|
ASH 2022 Highlights with Dr. Aaron Goodman ”Papa Heme”
|
Dec 20, 2022 |
|
HER2+ SABCS 2022 Highlights with Dr. Erika Hamilton
|
Dec 19, 2022 |
|
HR+ SABCS 2022 Highlights with Dr. Stephanie Graff
|
Dec 15, 2022 |
|
CDK4/6i in HR+ SABCS 2022 Highlights with Dr. Sara Tolaney
|
Dec 13, 2022 |
|
Upper Gastrointestinal (GI) Cancer Algorithm with Dr. Rutika Mehta
|
Nov 25, 2022 |
|
Triple Negative Breast Cancer (TNBC) Algorithm with Dr. Shipra Gandhi
|
Nov 17, 2022 |
|
HER2-positive Breast Cancer Algorithm with Dr. Erika Hamilton
|
Nov 08, 2022 |
|
Hormone Positive Breast Cancer Algorithm with Dr. Stephanie Graff
|
Nov 08, 2022 |
|
Melanoma ESMO 2022 Highlights with Dr. Sapna Patel
|
Nov 08, 2022 |
|
Lung Cancer ESMO 2022 Highlights with Dr. Joshua Reuss
|
Nov 08, 2022 |
|
Breast Cancer ESMO 2022 Highlights with Dr. Maryam Lustberg
|
Nov 08, 2022 |
|
GI Cancer ESMO 2022 Highlights with Dr. Rachna Shroff
|
Nov 08, 2022 |
|
Genitourinary Cancer ESMO 2022 Highlights with Dr. Toni Choueiri
|
Nov 08, 2022 |
|
Introduction: @OncBrothers - Drs. Rohit and Rahul Gosain, and their mission
|
Nov 07, 2022 |